7512-78-9

Basic information

• Product Name: 3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one
• CAS NO: 7512-78-9
• Molecular Formula: C₂₄H₁₈O₅
• Molecular Weight: 386.3967
• Mol File: 7512-78-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 645.8°C at 760 mmHg
• Flash Point: 230.2°C
• Density: 1.385g/cm³
• Vapor Pressure: 1.47E-17mmHg at 25°C
• Refractive Index: 1.681
• CAS DataBase Reference: 3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one(7512-78-9)
• EPA Substance Registry System: 3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one(7512-78-9)

Safety Data

• Hazardous Substances Data: 7512-78-9(Hazardous Substances Data)

Usage

Description

3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one is a complex chemical compound featuring a furan ring with a hydroxyl group and a benzyl group, as well as a benzodioxol ring and a phenyl group. This unique structure endows it with potential biological activities and applications in medicinal chemistry.

Uses

Used in Pharmaceutical Industry:
3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one is used as a pharmaceutical candidate for its potential biological activities. Its unique molecular structure allows it to be a promising agent for the development of new drugs.
Used in Biotechnology:
In the biotechnology field, 3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one is utilized for its potential applications in the study and manipulation of biological processes. Its complex structure may offer novel ways to interact with biological systems.
Used in Material Science:
3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one is also used in material science to explore its potential in creating new materials with unique properties. Its complex molecular structure may contribute to the development of advanced materials with specific applications.
Further research is necessary to fully understand the properties and potential uses of 3-(1,3-benzodioxol-5-yl)-4-benzyl-5-hydroxy-5-phenylfuran-2(5H)-one in these fields.

Upstream product

• 98-86-2 acetophenone 
• 169802-93-1 2-(benzo[d][1,3]dioxol-5-yl)-4-oxo-4-phenylbutanenitrile 
• 644-34-8 (E)-3-(benzo[d][1,3]dioxol-5-yl)-1-phenylprop-2-en-1-one 
• 120-57-0 piperonal 
• 169802-94-2 2-benzo[1,3]dioxol-5-yl-4-oxo-4-phenyl-butyric acid methyl ester 
• 100-52-7 benzaldehyde 

Relevant articles and documents

NONPEPTIDE ENDOTHELIN ANTAGONISTS I

Novel nonpeptide antagonists of endothelin I are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, myocardial ischemia, cerebral vasospasm, cerebral ischemia, cerebral infarction, cirrhosis, septic shock, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, atherosclerotic disorders including Raynaud's disease and restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, hemorrhagic shock, ischemic bowel disease, stroke, benign prosthatic hyperplasia (BPH), and diabetes.

Discovery of a novel series of orally active non-peptide endothelin-A (ET(A)) receptor-selective antagonists

-